Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The efficacy and tolerability of glecaprevir/pibrentasvir treatment in a real-world chronic hepatitis C patients cohort.
Yaras S, Demir M, Barutcu S, Yildirim AE, Gurel S, Ucbilek E, Kurtulmus IA, Kayhan MA, Vatansever S, Adanir H, Danis N, Duman S, Turan I, Ari D, Kose S, Alkim H, Harputluoglu MM, Dilber F, Akyildiz M, Cosar AM, Durak S, Sirin G, Kefeli A, Gokcan H, Avcioglu U, Ayyildiz T, Sezgin O, Akarsu M, Dincer D, Guzelbulut F, Gunsar F, Akarca US, Idilman R. Yaras S, et al. Among authors: gokcan h. Hepatol Forum. 2023 Sep 20;4(3):92-96. doi: 10.14744/hf.2023.2023.0001. eCollection 2023. Hepatol Forum. 2023. PMID: 37822314 Free PMC article.
Prognostic Utility of Hypokalemia in Cirrhotic Patients.
Kaplan M, Ateş I, Gökcan H, Kayhan MA, Kaçar S, Akpınar MY, Gökbulut V, Kayaçetin E. Kaplan M, et al. Among authors: gokcan h. Acta Gastroenterol Belg. 2018 Jul-Sep;81(3):398-403. Acta Gastroenterol Belg. 2018. PMID: 30350528 Free article.
Recommendations for Hepatitis B Immunoglobulin and Antiviral Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation.
Akarsu M, Onem S, Turan I, Adali G, Akdogan M, Akyildiz M, Aladag M, Balaban Y, Danis N, Dayangac M, Gencdal G, Gokcan H, Sertesen E, Gurakar M, Harputluoglu M, Kabacam G, Karademir S, Kiyici M, Idilman R, Karasu Z. Akarsu M, et al. Among authors: gokcan h. Turk J Gastroenterol. 2021 Sep;32(9):712-719. doi: 10.5152/tjg.2021.21608. Turk J Gastroenterol. 2021. PMID: 34609299 Free PMC article.
The prevalence of metabolic-associated fatty liver disease in the Turkish population: A multicenter study.
Yilmaz Y, Yilmaz N, Ates F, Karakaya F, Gokcan H, Kaya E, Adali G, Caliskan Kartal A, Sen I, Ahishali E, Ozenirler S, Koruk M, Uygun A, Idilman R; Turkish Association for the Study of the Liver (TASL); Fatty Liver Diseases Special Interest Groups. Yilmaz Y, et al. Among authors: gokcan h. Hepatol Forum. 2021 May 21;2(2):37-42. doi: 10.14744/hf.2021.2020.0033. eCollection 2021 May. Hepatol Forum. 2021. PMID: 35783905 Free PMC article.
Prevalence and characteristics of bone disease in cirrhotic patients.
Gokcan H, Kayhan MA, Demir SO, Kacar S, Cam P, Kaplan M, Daylak R, Oztuna D, Kuran SÖ, Ari D. Gokcan H, et al. Hepatol Forum. 2020 May 21;1(2):48-52. doi: 10.14744/hf.2020.2020.0007. eCollection 2020 May. Hepatol Forum. 2020. PMID: 35949442 Free PMC article.
Factors associated with the development of extrahepatic malignancy in patients with nonalcoholic fatty liver disease: a single-center longitudinal study.
Gumussoy M, Koc O, Karatas G, Ozercan M, Ellik Z, Duman S, Kiremitci S, Gokcan H, Elhan AH, Savas B, Idilman R. Gumussoy M, et al. Among authors: gokcan h. Eur J Gastroenterol Hepatol. 2022 Nov 1;34(11):1172-1177. doi: 10.1097/MEG.0000000000002448. Epub 2022 Sep 10. Eur J Gastroenterol Hepatol. 2022. PMID: 36170687
47 results